{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:41:33Z","timestamp":1774521693931,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["contract 75N93020C00038"],"award-info":[{"award-number":["contract 75N93020C00038"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH HEAL","award":["contract HHSN272201800047C"],"award-info":[{"award-number":["contract HHSN272201800047C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-026-01422-0","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T10:35:21Z","timestamp":1771410921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using the HPV vaccine as a public health case study for identifying potential barriers to a Fentanyl vaccine"],"prefix":"10.1186","volume":"23","author":[{"given":"Jennifer A.","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elissa R.","family":"Weitzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"1422_CR1","unstructured":"CDC National Center for Health Statistics. U.S. Overdose Deaths Decrease in 2023, First Time Since 2018. May 15. 2024. Accessed November 6, 2024. https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2024\/20240515.htm#:~:text=The%20new%20data%20show%20overdose,psychostimulants%20(like%20methamphetamine)%20increased"},{"issue":"14","key":"1422_CR2","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1001\/jama.2022.2847","volume":"327","author":"J Friedman","year":"2022","unstructured":"Friedman J, Godvin M, Shover CL, Gone JP, Hansen H, Schriger DL. Trends in drug overdose deaths among US Adolescents, January 2010\u2013June 2021. JAMA. 2022;327(14):1398. https:\/\/doi.org\/10.1001\/jama.2022.2847.","journal-title":"JAMA"},{"issue":"50","key":"1422_CR3","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.15585\/mmwr.mm7150a2","volume":"71","author":"LJ Tanz","year":"2022","unstructured":"Tanz LJ, Dinwiddie AT, Mattson CL, O\u2019Donnell J, Davis NL. Drug overdose deaths among persons aged 10\u201319 years\u2014United States, July 2019\u2013December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(50):1576\u201382. https:\/\/doi.org\/10.15585\/mmwr.mm7150a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Supplement1","key":"1422_CR4","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1093\/cid\/ciac344","volume":"75","author":"ER Weitzman","year":"2022","unstructured":"Weitzman ER, Kossowsky J, Blakemore LM, et al. Acceptability of a Fentanyl vaccine to prevent opioid overdose and need for personalized Decision-making. Clin Infect Dis. 2022;75(Supplement1):S98\u2013109. https:\/\/doi.org\/10.1093\/cid\/ciac344.","journal-title":"Clin Infect Dis"},{"key":"1422_CR5","doi-asserted-by":"publisher","unstructured":"Raleigh MD, Peterson SJ, Laudenbach M et al. Safety and efficacy of an oxycodone vaccine: addressing some of the unique considerations posed by opioid abuse. PLos One. 2017;12(12):e0184876. https:\/\/doi.org\/10.1371\/journal.pone.0184876","DOI":"10.1371\/journal.pone.0184876"},{"issue":"24","key":"1422_CR6","doi-asserted-by":"publisher","first-page":"126082","DOI":"10.1016\/j.vaccine.2024.06.049","volume":"42","author":"ER Weitzman","year":"2024","unstructured":"Weitzman ER, Pierce SE, Blakemore LM, et al. Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting Fentanyl. Vaccine. 2024;42(24):126082. https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.049.","journal-title":"Vaccine"},{"key":"1422_CR7","doi-asserted-by":"publisher","unstructured":"Weitzman ER, Alegria M, Caplan A et al. Social complexity of a fentanyl vaccine to prevent opioid overdose conference proceedings: Radcliffe Institute for Advanced Study conference proceedings. Vaccine. 2025;44:126324. https:\/\/doi.org\/10.1016\/j.vaccine.2024.126324","DOI":"10.1016\/j.vaccine.2024.126324"},{"key":"1422_CR8","unstructured":"Centers for Disease Control and Prevention, About HPV, July. 3, 2024. Accessed November 6, 2024. https:\/\/www.cdc.gov\/hpv\/about\/"},{"key":"1422_CR9","unstructured":"Centers for Disease Control and Prevention. Child and Adolescent Immunization Schedule by Age. Immunization Schedules. June 27, 2024. Accessed November 6. 2024. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child-adolescent.html"},{"issue":"35","key":"1422_CR10","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.15585\/mmwr.mm7035a1","volume":"70","author":"C Pingali","year":"2021","unstructured":"Pingali C, Yankey D, Elam-Evans LD, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 Years\u2014United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(35):1183\u201390. https:\/\/doi.org\/10.15585\/mmwr.mm7035a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1422_CR11","unstructured":"Centers for Disease Control and Prevention. HPV Vaccination. August 20. 2024. Accessed November 6, 2024. https:\/\/www.cdc.gov\/hpv\/vaccines\/"},{"key":"1422_CR12","unstructured":"Darrow JJ, Kesselheim AS. A new wave of vaccines for non-communicable diseases: what are the regulatory challenges? Food Drug Law J. 2015;70(2):243\u2013258."},{"issue":"5","key":"1422_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jadohealth.2013.07.035","volume":"53","author":"DH Bernat","year":"2013","unstructured":"Bernat DH, Gerend MA, Chevallier K, Zimmerman MA, Bauermeister JA. Characteristics associated with initiation of the human papillomavirus vaccine among a national sample of male and female young adults. J Adolesc Health. 2013;53(5):630\u20136. https:\/\/doi.org\/10.1016\/j.jadohealth.2013.07.035.","journal-title":"J Adolesc Health"},{"key":"1422_CR14","doi-asserted-by":"publisher","unstructured":"Bodson J, Wilson A, Warner EL, Kepka D. Religion and HPV vaccine-related awareness, knowledge, and receipt among insured women aged 18\u201326 in Utah. Plos One. 2017;12(8):e0183725. https:\/\/doi.org\/10.1371\/journal.pone.0183725","DOI":"10.1371\/journal.pone.0183725"},{"key":"1422_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ypmed.2016.11.019","volume":"95","author":"G Radisic","year":"2017","unstructured":"Radisic G, Chapman J, Flight I, Wilson C. Factors associated with parents\u2019 attitudes to the HPV vaccination of their adolescent sons: a systematic review. Prev Med. 2017;95:26\u201337. https:\/\/doi.org\/10.1016\/j.ypmed.2016.11.019.","journal-title":"Prev Med"},{"key":"1422_CR16","doi-asserted-by":"publisher","first-page":"106849","DOI":"10.1016\/j.ypmed.2021.106849","volume":"153","author":"CE Peterson","year":"2021","unstructured":"Peterson CE, Silva A, Goben AH, et al. Stigma and cervical cancer prevention: a scoping review of the U.S. literature. Prev Med. 2021;153:106849. https:\/\/doi.org\/10.1016\/j.ypmed.2021.106849.","journal-title":"Prev Med"},{"issue":"3","key":"1422_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/1090198106292022","volume":"34","author":"AL Friedman","year":"2007","unstructured":"Friedman AL, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behav. 2007;34(3):471\u201385. https:\/\/doi.org\/10.1177\/1090198106292022.","journal-title":"Health Educ Behav"},{"issue":"5","key":"1422_CR18","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1542\/peds.2011-0950","volume":"128","author":"CG Dorell","year":"2011","unstructured":"Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008\u20132009. Pediatrics. 2011;128(5):830\u20139. https:\/\/doi.org\/10.1542\/peds.2011-0950.","journal-title":"Pediatrics"},{"issue":"1","key":"1422_CR19","doi-asserted-by":"publisher","first-page":"2214054","DOI":"10.1080\/21645515.2023.2214054","volume":"19","author":"AH McKenzie","year":"2023","unstructured":"McKenzie AH, Shegog R, Savas LS, et al. Parents\u2019 stigmatizing beliefs about the HPV vaccine and their association with information seeking behavior and vaccination communication behaviors. Hum Vaccines Immunother. 2023;19(1):2214054. https:\/\/doi.org\/10.1080\/21645515.2023.2214054.","journal-title":"Hum Vaccines Immunother"},{"issue":"5","key":"1422_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1542\/peds.2009-3059","volume":"126","author":"V Delaney-Black","year":"2010","unstructured":"Delaney-Black V, Chiodo LM, Hannigan JH, et al. Just say I don\u2019t: lack of concordance between teen report and biological measures of drug use. Pediatrics. 2010;126(5):887\u201393. https:\/\/doi.org\/10.1542\/peds.2009-3059.","journal-title":"Pediatrics"},{"issue":"6","key":"1422_CR21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/21645515.2016.1141158","volume":"12","author":"ML Kasting","year":"2016","unstructured":"Kasting ML, Shapiro GK, Rosberger Z, Kahn JA, Zimet GD. Tempest in a teapot: a systematic review of HPV vaccination and risk compensation research. Hum Vaccines Immunother. 2016;12(6):1435\u201350. https:\/\/doi.org\/10.1080\/21645515.2016.1141158.","journal-title":"Hum Vaccines Immunother"},{"issue":"5","key":"1422_CR22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ypmed.2013.05.013","volume":"57","author":"GD Zimet","year":"2013","unstructured":"Zimet GD, Rosberger Z, Fisher WA, Perez S, Stupiansky NW. Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation. Prev Med. 2013;57(5):414\u20138. https:\/\/doi.org\/10.1016\/j.ypmed.2013.05.013.","journal-title":"Prev Med"},{"issue":"4","key":"1422_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1086\/260352","volume":"83","author":"S Peltzman","year":"1975","unstructured":"Peltzman S. The effects of automobile safety regulation. J Polit Econ. 1975;83(4):677\u2013725. https:\/\/doi.org\/10.1086\/260352.","journal-title":"J Polit Econ"},{"key":"1422_CR24","doi-asserted-by":"publisher","first-page":"103513","DOI":"10.1016\/j.drugpo.2021.103513","volume":"100","author":"WC Tse","year":"2022","unstructured":"Tse WC, Djordjevic F, Borja V, et al. Does Naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a \u2018moral hazard\u2019 associated with Naloxone supply. Int J Drug Policy. 2022;100:103513. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103513.","journal-title":"Int J Drug Policy"},{"key":"1422_CR25","doi-asserted-by":"publisher","first-page":"103980","DOI":"10.1016\/j.drugpo.2023.103980","volume":"114","author":"E Bruzelius","year":"2023","unstructured":"Bruzelius E, Cerd\u00e1 M, Davis CS, et al. Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: evidence from 44 US States. Int J Drug Policy. 2023;114:103980. https:\/\/doi.org\/10.1016\/j.drugpo.2023.103980.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"1422_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.pedhc.2015.11.013","volume":"30","author":"F DiAnna Kinder","year":"2016","unstructured":"DiAnna Kinder F. Parental refusal of the human papillomavirus vaccine. J Pediatr Health Care. 2016;30(6):551\u20137. https:\/\/doi.org\/10.1016\/j.pedhc.2015.11.013.","journal-title":"J Pediatr Health Care"},{"issue":"3","key":"1422_CR27","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1542\/peds.2014-0442","volume":"134","author":"RB Perkins","year":"2014","unstructured":"Perkins RB, Clark JA, Apte G, et al. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics. 2014;134(3):e666\u201374. https:\/\/doi.org\/10.1542\/peds.2014-0442.","journal-title":"Pediatrics"},{"key":"1422_CR28","doi-asserted-by":"publisher","first-page":"101240","DOI":"10.1016\/j.pmedr.2020.101240","volume":"20","author":"KK Walker","year":"2020","unstructured":"Walker KK, Owens H, Zimet G. We fear the unknown: emergence, route and transfer of hesitancy and misinformation among HPV vaccine accepting mothers. Prev Med Rep. 2020;20:101240. https:\/\/doi.org\/10.1016\/j.pmedr.2020.101240.","journal-title":"Prev Med Rep"},{"issue":"6","key":"1422_CR29","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.jadohealth.2005.09.010","volume":"37","author":"GD Zimet","year":"2005","unstructured":"Zimet GD. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health. 2005;37(6):S17\u201323. https:\/\/doi.org\/10.1016\/j.jadohealth.2005.09.010.","journal-title":"J Adolesc Health"},{"issue":"6","key":"1422_CR30","doi-asserted-by":"publisher","first-page":"e20172312","DOI":"10.1542\/peds.2017-2312","volume":"141","author":"LA Shay","year":"2018","unstructured":"Shay LA, Baldwin AS, Betts AC, et al. Parent-provider communication of HPV vaccine hesitancy. Pediatrics. 2018;141(6):e20172312. https:\/\/doi.org\/10.1542\/peds.2017-2312.","journal-title":"Pediatrics"},{"issue":"11","key":"1422_CR31","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1158\/1055-9965.EPI-21-0733","volume":"30","author":"WY Kong","year":"2021","unstructured":"Kong WY, Bustamante G, Pallotto IK, et al. Disparities in healthcare providers\u2019 recommendation of HPV vaccination for U.S. adolescents: a systematic review. Cancer Epidemiol Biomarkers Prev. 2021;30(11):1981\u201392. https:\/\/doi.org\/10.1158\/1055-9965.EPI-21-0733.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"1422_CR32","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1111\/j.1651-2227.2008.00958.x","volume":"97","author":"KL Ishibashi","year":"2008","unstructured":"Ishibashi KL, Koopmans J, Curlin FA, Alexander KA, Ross LF. Paediatricians\u2019 attitudes and practices towards HPV vaccination. Acta Paediatr. 2008;97(11):1550\u20136. https:\/\/doi.org\/10.1111\/j.1651-2227.2008.00958.x.","journal-title":"Acta Paediatr"},{"issue":"10051","key":"1422_CR33","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(16)31573-2","volume":"388","author":"SE Hadland","year":"2016","unstructured":"Hadland SE, Wood E, Levy S. How the paediatric workforce can address the opioid crisis. Lancet. 2016;388(10051):1260\u20131. https:\/\/doi.org\/10.1016\/S0140-6736(16)31573-2.","journal-title":"Lancet"},{"issue":"1","key":"1422_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41541-025-01083-3","volume":"10","author":"A Angelidou","year":"2025","unstructured":"Angelidou A, Koster JA, Sherman AC, et al. Product and trial design considerations on the path towards a vaccine to combat opioid overdose. Npj Vaccines. 2025;10(1):35. https:\/\/doi.org\/10.1038\/s41541-025-01083-3.","journal-title":"Npj Vaccines"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01422-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01422-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01422-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:32:29Z","timestamp":1774517549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01422-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1422"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01422-0","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.A.R. has no competing interests. E.R.W. reports that administrative support for the conference was provided by Harvard University Radcliffe Institute for Advanced Study. E.R.W. is an advisor to Ovax, Inc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}